+ All Categories
Home > Documents > INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS...

INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS...

Date post: 14-Jan-2016
Category:
Upload: edmund-cox
View: 214 times
Download: 0 times
Share this document with a friend
Popular Tags:
46
INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM
Transcript
Page 1: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

INTRODUCTION AND GENERAL PROBLEMS OF MODERN

MEDICAL THERAPY. THERAPY OF DISEASES OF THE

NERVOUS SYSTEM

Page 2: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

KINDS OF TREATMENT

• Ethiotropic treatment (antibacterials, antidotes)• Pathognomonic treatment (antihypertensive,

antiarrhythmic, antiinflammatory agents, antidepressants)

• Symptomatic treatment (pain-killers, antipyretics)

• Substitutional therapy (enzymes, hormonal medicines, vitamines)

• Preventive treatment (vaccines, antiviral drugs)

Page 3: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

Terminology

• Symptom - any sensation or change in bodily function that is experienced by a patient and is associated with a particular disease

• SYNDROME - a pattern of symptoms indicative of some disease (Reye's syndrome - acquired brain disorder following acute viral infections (especially influenza or chicken pox) in young children )

Page 4: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

FACTORS THAT INFLUENCING ON TREATMENT EFFECTICITY

ExogenicExogenic

Chemical structure and Chemical structure and physical&chemical physical&chemical characteristics of agents, medicinal form, ways of characteristics of agents, medicinal form, ways of using, drug dose, dietery, environmental factors using, drug dose, dietery, environmental factors (metheorological, etc.)(metheorological, etc.)

EndogenicEndogenic

Age, sex, menstruation, pregnancy, combined Age, sex, menstruation, pregnancy, combined pathological stagespathological stages

Page 5: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

MEDICINAL FORM AND WAYS OF USING

• Biofarmaciya is engaged in the study of influence of medical form on a pharmacodynamics and pharmacokinetics of medications.

• Bioavailability of medications – complex of pharmacokinetic processes due to which the effective concentration of medication is created in the area of specific receptors (part of preparation, which got in blood, in relation to a that amount which was applied)

Page 6: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

INFLUENCE OF PATIENT’ S SEX ON DRUGS ACTION

• Morphin, nicotine, strychnin - the sensitiveness of women is more high

• Changes of metabolism of theophyllin, methylprednisolon, paracetamol in the different phases of menstrual cycle

• Pregnancy – absorbtion gets worse, biotransformation of medications is slowed

• Menstruation - anticoagulants can cause the massive uterine bleeding

Page 7: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

INFLUENCE OF BIOLOGICAL RHYTHMS• Administration of GKS between 6-8 h. of morning • At night maximal sensitiveness of bronchial tubes

to histamin and acetilcholin, it is that is why expedient to appoint the prolonged forms of theophyllin in the evening

• Hypertensive crises more frequent develop between 16-24 hours

• Maximal diuretic action at the reception of diuretic preparations is observed in the morning (to 10 h.)

• Toxicity of haloperidol for a day long differs in 5 times

Page 8: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

INFLUENCE OF PATHOLOGICAL PROCESSES ON MEDICATIONS ACTION

• Diminishing of tolerance to cardiac glycosides - at miocarditis

• Cardiac glycosides operate in the conditions of cardiac insufficiency

• Paracetamol and other antipyretics reduce a temperature only at hyperpyrexia

• Slowing of metabolism, growth of toxicity of medications at pathology of liver

• Slowing of leadingout of medications at pathology of kidneys

• Inhibition of absorbtion of fat-disolved vitamins at violation of biliation

• At smoking the risk of tromboembolic complications grows at the reception of anticoagulants, hormonal contraceptives

Page 9: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

BASIC SYMPTOMS AND SYNDROMES OF DEFEAT OF NERVOUS SYSTEM

• PAIN

• DIZZINESS

• INCREASE OF INTRACRANEAL PRESSURE AND HYDROCRANIUM DEMENCIYA

• VIOLATION OF CONSCIOUSNESS

• COMMA

Page 10: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

PAINDevelopment of sharp pain is related to the

pain irritations of superficial and deep fabrics and internalss or parafunction smooth musculature of internalss without the damage of fabrics. The neurological reasons of sharp pain -traumatic, infectious, dismetabolic and other damages of CNS.

The mechanisms of chronic pain depending on a prevailing role in its genesis of different departments of the nervous system divide into peripheral, central, united peripheral and central, psycological

Page 11: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

Headache• Headache— one of the most frequent

symptoms of different diseases. It is arisen up as a result of irritation of nervous completions of vessels of chairman or brain-tunics and depending on reason has the features. Nosotropic types of headache: it is vascular – headache of muscular tension ;- liquorodynamic ; - neuralgic; - hallucinogenic (psychalgya); headache of the mixed genesis.

Page 12: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

Dizziness • Dizziness is feeling of loss of orientation of body

in space. Meets at disfunction of the sensory antihunt systems - vestibular, visile and somatosensor. Dizzinesses are quite often accompanied by :

• falling • nystagmus • an ataxia in extremities • visceral violations (paleness, sweating, change

of pulse and AP, nausea, vomitting, diarhea).

Page 13: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

Increasing of intracraneal pressure

• The increase of intracraneal pressure can be conditioned: – by the presence of intracraneal volume process; – by the increase of volume of cerebrum (edema of the brain); – by the increase of level of cerebrospinal liquid at a hydrocephaly

• – by the increase of volume of blood at vasodilatation in the conditions of hypercapnia.

Page 14: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

DEMENTIA

Dementia is the state, which arises up as a result of organic defeat of cerebrum and characterized violation of intellectual activity, worsening of memory of thought, understanding, language, cognitive functions.

Dementia meets for old years people (more senior 65 years -10 %, more senior 80 years - 20 %).

Select dementia, associated with degenerative neurological diseases and those which develop on a background various neurological and somatic diseases (intoxications, tumours, craniocerebral trauma, metabolic violations, epilepsy, neuroinfection, internalss conditioned illnesses, and by the inherited somatic and neurological diseases).

Page 15: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

CONFUSED CONSCIOUSNESS

Under confusing of consciousness understand impossibility to think with sufficient speed and clarity. Patients do not perceive that surrounds them, can not estimate a situation and does not control the function of pelvic organs. Types of violation of consciousness: stupor, sopor coma , delirium, twilight state of consciousness

Page 16: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

Stupor - is a partial exception of consciousness with the maintainance of verbal contact on a background enhanceable perception of all external irritants decline of own activity. Sopor - psychical and physical activity expressed to the minimum, a reaction on linguistic commands absents and is inadequate. Coma characterized the protracted oppression and loss of consciousness with the making progress deepening of disorders vitally of important organs, up to death of brain. Death of brain is the state at which the brain is damaged nonreversible and does not function, and cardiac and respiratory functions are supported artificially.

Page 17: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

COMA

• The comatose states can be conditioned: — by violations of exchange and intoxications of endogenous or exogenous character;

• — by cerebral defeats.

Page 18: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

Types of the comatose states

• A diabetic coma

• Hypoglycemia coma

• Cerebral coma

• Uremic coma

• Hepatic coma

• Coma at Addison illness

• Thyroid coma

Page 19: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

NERVOUS SYSTEM DISEASES• Divided on: disease of the central, peripheral and

vegetative nervous system. In dependence on pathogeny of nervous disease divide into three groups: Inflammatory diseases (meningitis, encephalitis, myelities).

• Vascular diseases (ischemic and hemorragic strokes of cerebrum, migraine, sharp necrotizing hemorragic stroke).

• Demyelinating (degenerative distrophical) diseases (disseminated sclerosis, sharp disseminated encephalomyelitis, syringomyelia, lateral amyotrophic sclerosis)

Page 20: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

MENINGITIS

• Meningitises are sharp infectious diseases with the overwhelming defeat of arachnoid and soft shells of cerebral and (or) spinal brain.

• Meningitises can run across in form leptomeningitis (inflammation of soft and arachnoid shells), to the arachnoiditis (isolated inflammation of arachnoid shell, meets rarely) and pachymeningitis (inflammation of hard cerebral shell)

Page 21: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

MENINGITIS. CLINICAL SYMPTOMS

• Meningeal syndrome: headache, intoxication, meningeal symptom, change of composition of neurolymph and immunity.

• Headache- holding apart, mainly in frontal, temporal or cervical areas.

• Meningeal symptoms: Kernig symptom , Brudzinsky. Kernig symptom: overhead is rigidity of cervical muscles; lower: initial position: a patient lies on the back, a leg is arcuated at right angles in hip and knee joints. At the attempt of straightening there is tension of muscles of back surface of thigh in a knee-joint.

Brudzinsky symptom: overhead: consists in bending of thigh and shin at an attempt to incline a chairman lying on the back of patient forward; lower— in bending of contralateral leg at the attempt of straightening and raising of other leg.

An important symptom of meningeal syndrome is general hiperesthesia. Patients painfully react on any external irritants — bright light, loud sound, touch. Level of lg А, Ig G, Ig М changes in blood serum

Page 22: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.
Page 23: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

Brudzinsky symptom

Page 24: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.
Page 25: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

Central Nervous System Stimulants • Stimulants are drugs that exert their action

through excitation of the central nervous system. Psychic stimulants include caffeine, cocaine, and various amphetamines. These drugs are used to enhance mental alertness and reduce drowsiness and fatigue.

• Stimulants increase alertness, attention, and energy, which are accompanied by increases in blood pressure, heart rate, and respiration.

Page 26: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.
Page 27: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

AmphetamineLevoamphetamine (Benzedrine), dextroamphetamine

(Dexedrine), and methamphetamine (Methedrine) • These agents produce a feeling of well being and euphoria.

Cocaine and amphetamine have a significant abuse potential because of these mood enhancing effects. Tachyphylaxis or tolerance to the stimulating actions of these agents can develop. These agents produce an increase in systemic arterial blood pressure. Heart rate can either decrease or increase depending on the levels of the drug. Drug toxicity effects multiple organ systems and can result in arrhythmias, hypertension, psychosis and convulsions. The local anesthetic activity of cocaine can also contribute to rhythm disturbances.

Clinical Therapeutics of CNS Stimulants• 1) Because of its local anesthetic activity, cocaine has some

limited uses as a oral, nasal and ophthalmic local anesthetic.• 2) Appetite suppression - amphetamine and analogs• 3) Narcolepsy - methylphenidate, amphetamine analogs• 4) Attention deficient disorder with hyperactivity (ADHD) -

methylphenidate, amphetamine and analogs

Page 28: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

Tolerance and Dependence• Regular use of amphetamines induces tolerance to some

effects, which means that more and more of the drug is required to produce the desired effects. Tolerance does not develop to all effects at the same rate, however; indeed, there may be increased sensitivity to some of them.

• Chronic users may also become psychologically dependent on amphetamines. Psychological dependence exists when a drug is so central to a person's thoughts, emotions, and activities that the need to continue its use becomes a craving or compulsion. Experiments have shown that animals, when given a free choice, will readily operate pumps that inject them with cocaine or amphetamine. Animals dependent on amphetamines will work hard to get more of the drug.

• Physical dependence occurs when the body has adapted to the presence of the drug, and withdrawal symptoms occur if its use is stopped abruptly. The most common symptoms of withdrawal among heavy amphetamine users are fatigue, long but troubled sleep, irritability, intense hunger, and moderate to severe depression, which may lead to suicidal behavior. Fits of violence may also occur. These disturbances can be temporarily reversed if the drug is taken again.

Page 29: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.
Page 30: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

Antidepressant Drugs • All are effective in relieving depression, but they

differ in their adverse effects.• All must be taken for 2 to 4 weeks before

depressive symptoms improve.• They are given orally, absorbed from the small

bowel, enter the portal circulation, and circulate through the liver, where they undergo extensive first-pass metabolism before reaching the systemic circulation.

• They are metabolized by the cytochrome P450 enzymes in the liver. Many antidepressants and other drugs are metabolized by the 2D6 or 3A4 subgroup of the enzymes.

Page 31: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

Antidepressant Drugs indications for use

Antidepressant drug therapy may be indicated if depressive symptoms persist at least 2 weeks, impair social relationships or work performance, and occur independently of life events. In addition, antidepressants are increasingly being used for treatment of anxiety disorders. TCAs may be used in children and adolescents in the management of enuresis (bedwetting or involuntary urination resulting from a physical or psychological disorder). In this setting, a TCA may be given after physical causes (eg, urethral irritation, excessive intake of fluids) have been ruled out. TCAs are also commonly used in the treatment of neuropathic pain. MAOIs are considered third-line drugs, largely because of their potential for serious interactions with certain foods and other drugs.

Page 32: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.
Page 33: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

Tranquilizers• Tranquilizers are divided into a Major Tranquilizer and Minor

Tranquilizer group. • Major Tranquilizers include phenothiazines, indoles,

thioxanthenes, butyrophenones, piperazine compounds, and piperidine compounds. Trade names include drugs such as Thorazine, Haldol, Clozaril and Risperdal. These drugs are referred to as Neuroleptics and are most commonly prescribed as anti-psychotics. This type of tranquilizer is not widely abused.

• Minor Tranquiliers are the more common of the tranquilizers. These include the Benzodiazepines, known by trade names such as Valium, Xanax, Serax, Ativan, Klonopin, Librium and Tranxene. There are also combination drugs such as Librax. These drugs are very commonly prescribed as anti-anxiety drugs, or anxiolytics. They are often referred to as Sedative/Hypnotics. They are central nervous system depressants with specific sites of action. Slang references to these drugs include Libs, Tranks, Benzos, and Vees.

• The primary route of administration for these medications is oral, swallowed as a tablet, capsule, or liquid. They are also available in solution form for intravenous use.

Page 34: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

Effects• The minor tranquilizers induce a feeling of calm and relaxation.

Depending on the medication and dosage this can range from feelings of mild euphoria to states of drowsiness, confusion, and lightheadedness. Effects can include hostility, blurred vision, hallucinations, lethargy, headaches, memory loss, disorganized thinking, and irritability. Other common effects include impaired motor function, dry mouth, nausea, vomiting, and sweating. Certain Benzodiazepines, including Valium, can produce toxic reactions when combined with alcohol.

• The Benzodiazepines (Minor Tranquilizers) can be addictive even at prescribed dosages if the medication is administered for long periods of time. The withdrawal process can be painful and even life-threatening with some of the Benzodiazepines. Physical withdrawal symptoms can include general pain, stomach cramps, diarrhea, flu-like symptoms, and heart palpitations. There is also the possibility of seizure with certain medications. The withdrawal can also produce psychosis, hallucinations, delusions, paranoia, and depression.

Page 35: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

SEDATIVE - HYPNOTIC AGENTS • Drug Classes of Sedative-Hypnotics• Barbiturates• Benzodiazepines• Alcohols/Imidazopyridine•• Barbiturates:• Duration of Action

Onset• - Phenobarbital Long (6-12 h)

20 min• - Pentobarbital Intermediate (4-6 h)

3 min• - Secobarbital Short-Intermediate (3-6 h)

2 min• - Thiopental/ Short (15- 30 min)

few seconds• Methohexital• [All are derivatives of barbituric acid]

Page 36: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

• 1. Sites of Action:• Barbiturates act at multiple levels of

the CNS. Sedative-Hypnotic effect involves, in particular, the reticular activating system.

• 2. Mechanism of Action:• - facilitate the action of GABA at

GABAA receptors by increasing the duration of channel openings (bind at a distinct site from that bound by benzodiazepines)

• - reduce glutamate-induced depolarization via inhibitory action on AMPA-type glutamate receptors

• - at high doses, reduce the responsiveness of voltage-dependent Na+ channels and directly active GABAA receptors

Page 37: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

3. CNS effects:Dose-dependent progression: (lower margin of

safety) Sedation → ‘Hypnosis’ → Anesthesia →

Coma → Death* Anticonvulsant/antiepileptic

- all barbiturates stop convulsions in progress if given IV at high enough dosage- some can prevent seizures (eg. phenobarbital), but are not drugs of first choice owing to sedative effect (except for children); used to maintain control of status epilepticus

For animal surgery, methohexital may be used as an induction agent only. Pentobarbital (Nembutal®) used, but has a very low margin of safety in rodents and guinea pigs (consequently, often agent of choice for rapid, humane euthanasia)

Page 38: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

Adverse effects:

- respiratory depression via action on respiratory center in the medulla is the usual cause of death with overdose; depression occurs at supra-hypnotic doses

- generalized CNS depression: impaired motor and cognitive skills

- uncommon: rash, dermatitis, decreased red blood cells and platelet

- physiological and psychological dependency: significant incidence of abuse

Page 39: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

Benzodiazepines:Duration of Action

- Flurazepam Long (30-100h) [pro-drug]

- Diazepam “[active metabolites]

- Temazepam Intermediate (10-40h)

- Triazolam Short (1-3h)

Page 40: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.
Page 41: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

Effects and uses:- drugs of choice for sedation and ‘hypnosis’ (higher margin of safety)

flurazepam: long-acting pro-drugtemazepam: slowly absorbed, intermediate acting drug with no

active metabolites; most highly prescribed hypnotictriazolam: rapid but short-acting drugdiazepam (Valium®): long-acting drug; may be useful as adjunct

in animal surgery- at sedative doses may cause euphoria and ‘disinhibition’- anticonvulsant (primary drug for initial treatment of status epilepticus)- anxiolytic- muscle relaxation (used in spasticity; largely via effect in spinal cord)- ethanol withdrawal

Page 42: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

Adverse reactions:- ‘hangover’ (esp. with benzodiazepines with long half-lives: diazepam)- early morning awakening for benzodiazepines with short half-lives: triazolam- impaired motor and cognitive skills- anterograde amnesia- chronic use/dependence: more intense withdrawal symptoms with benzodiazepines having short half-lives ‘rebound’ insomnia (and/or anxiety), restlessness and even seizures (severity and frequency of dependence less than that found for barbiturates)

Page 43: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

Alcohols/Imidazopyridine:

Duration of Action

- Chloral Hydrate Long (6-10h) [pro-drug]

- Zolpidem Short (several hours)

- Zaleplon Short (1-3h)

Page 44: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

1. Chloral hydrate rapidly metabolized in liver to triethanolamine - pharmacologically active (also metabolized to trichloroacetic acid, which is toxic and may accumulate); mechanism of action is not known- oft-used sedative-hypnotic for animals undergoing surgery- institutional use2. Zolpidem: non-benzodiazepine that acts via subtype of GABAA receptor- an effective, short-acting hypnotic agent (most highly prescribed hypnotic) - much lower risk of tolerance and dependency; but some mild cognitive impairment during onset- little anticonvulsant or muscle relaxant effects3. Zaleplon: an alternative non-benzodiazepine that also acts via the GABAA receptor- similar to Zolpidem, but without effects on cognitive function

Page 45: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

Narcotic Analgesic Drugs

Page 46: INTRODUCTION AND GENERAL PROBLEMS OF MODERN MEDICAL THERAPY. THERAPY OF DISEASES OF THE NERVOUS SYSTEM.

Recommended